Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Arecor Therapeutics scientist hopeful that artificial pancreas "edging closer"

Arecor Therapeutics scientist hopeful that artificial pancreas "edging closer"

Arecor Therapeutics PLC (AIM:AREC) CEO Sarah Howell & scientist Rafic Sukar visited the Proactive London studio on World Diabetes Day to provide an update on the work they're doing to make life easier for those suffering with the disease. Sukar was diagnosed with type 1 diabetes as an infant and now works on developing new treatments.

The pair explains some of the challenges that diabetics face each day in managing the condition, and reveal their predictions for when a fully closed loop artificial pancreas system will be available to patients.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK